BioAZ raises $1M to accelerate biotech innovation for animal well-being
BioAZ is proud to announce a $1M (€900k) fundraising round with the support of its historical shareholders and leading veterinary business angels.
News
Multi-million dollar funding round accelerates MI:RNA mission to improve global veterinary diagnostics
Pioneering molecular diagnostics company MI:RNA, which uses biomarkers and advanced modelling to diagnose veterinary disease earlier, has reached a growth milestone with the completion of an oversubscribed funding round.
AHA Welcomes Antigenesis, Developing New Cancer Therapies for Pets.
Antigenesis joins the AHA portfolio with a focus on creating targeted antibody-based cancer treatments for pets. With early funding secured and lead molecules in preclinical development, the company is working to bring new options to a fast-growing area of veterinary medicine.
SageTech Medical Secures £3.6m Innovate UK Funding
We are delighted to congratulate SageTech Medical, one of our portfolio companies, on securing £3.6 million in funding through Innovate UK's prestigious Grand Challenge programme.
Animal Health Angels backing innovation to tackle antimicrobial resistance
Antimicrobial resistance (AMR) is one of the defining challenges of our time. It affects animal health and welfare in practice and has profound potential consequences for human health. As vets, we understand the pressure to reduce reliance on antibiotics while still safeguarding our patients. Animal Health Angels, a group of veterinary and animal health professionals supporting early-stage innovation, has announced recent backing for three companies developing practical solutions to tackle AMR and antibiotic use in clinical settings: Zonova, FluoretiQ and NoBACZ.
Animal Health Angels backs Marleybones as part of £2.5M funding round
Marleybones, the UK’s premium dog-nutrition brand behind Pantry Fresh® meals, has closed a £2.5M funding round, and we’re proud to have taken part!